Progenity: Jill Howe

Jille Howe has joined to the board of directors of Progenity. She will also chair the audit committee and join the nominating and corporate governance committee. Howe is currently CFO of DTxPharma. Previously, she was treasurer and VP of finance at Gossamer Bio, and before that, she held controller and director of finance roles at Amplyx Pharmaceuticals, Receptos, and Somaxon Pharmaceuticals. Howe holds a BS in accountancy from San Diego State University.